Insights

Strategic Market Focus Novartis Oncology’s emphasis on addressing five key cancer areas plus its broad portfolio treating over 25 conditions presents numerous opportunities for tailored solutions in oncology treatment and diagnostics, particularly around breast, lung, melanoma, kidney cancers, and hematology.

Growth & Expansion Recent investments such as the $771 million facility expansion in North Carolina and new asset licensing agreements highlight Novartis's commitment to scaling manufacturing capabilities and pipeline expansion, indicating a need for suppliers, logistics, and innovative manufacturing solutions.

Digital Transformation The rollout of Salesforce's Agentforce 360 platform across global teams demonstrates Novartis's focus on streamlining operations through advanced technology, signaling potential demand for integrated digital solutions, CRM enhancements, and AI-driven analytics.

Innovative Partnerships Collaborations with biotech firms like Relation Therapeutics reflect a strategic approach to advancing pipeline growth, offering opportunities for technology providers in biotech licensing, joint research initiatives, and advanced drug discovery tools.

Financial & Market Position With revenues ranging from one to ten billion dollars and a substantial funding background, Novartis maintains a strong financial position, enabling investment in emerging technologies, sustainability initiatives, and global expansion, creating diverse avenues for future sales engagement.

Novartis Oncology Tech Stack

Novartis Oncology uses 8 technology products and services including Intelligize, Apache HBase, JD Edwards, and more. Explore Novartis Oncology's tech stack below.

  • Intelligize
    Data Management
  • Apache HBase
    Database
  • JD Edwards
    Enterprise
  • Plotly
    Javascript Graphics
  • Video.js
    Javascript Libraries
  • Shodan
    Network Security
  • SPARQL
    Programming Languages
  • PoolParty
    Search Marketing

Media & News

Novartis Oncology's Email Address Formats

Novartis Oncology uses at least 1 format(s):
Novartis Oncology Email FormatsExamplePercentage
First.Last@novartis.comJohn.Doe@novartis.com
89%
F.Last@novartis.comJ.Doe@novartis.com
5%
FiLast@novartis.comJoDoe@novartis.com
3%
FLast@novartis.comJDoe@novartis.com
3%

Frequently Asked Questions

What is Novartis Oncology's official website and social media links?

Minus sign iconPlus sign icon
Novartis Oncology's official website is novartis.com and has social profiles on LinkedIn.

What is Novartis Oncology's NAICS code?

Minus sign iconPlus sign icon
Novartis Oncology's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Novartis Oncology have currently?

Minus sign iconPlus sign icon
As of December 2025, Novartis Oncology has approximately 10K employees across 6 continents, including North AmericaEuropeAsia. Key team members include Vp & Medical Head Of Hematology Franchise At Novartis Oncology: S. N.Head Of Rlt Erp Process Optimization: A. Z.Head Oncology Jpls Region: D. N.. Explore Novartis Oncology's employee directory with LeadIQ.

What industry does Novartis Oncology belong to?

Minus sign iconPlus sign icon
Novartis Oncology operates in the Pharmaceutical Manufacturing industry.

What technology does Novartis Oncology use?

Minus sign iconPlus sign icon
Novartis Oncology's tech stack includes IntelligizeApache HBaseJD EdwardsPlotlyVideo.jsShodanSPARQLPoolParty.

What is Novartis Oncology's email format?

Minus sign iconPlus sign icon
Novartis Oncology's email format typically follows the pattern of First.Last@novartis.com. Find more Novartis Oncology email formats with LeadIQ.

How much funding has Novartis Oncology raised to date?

Minus sign iconPlus sign icon
As of December 2025, Novartis Oncology has raised $2.4B in funding. The last funding round occurred on Sep 16, 2020 for $2.1B.

Novartis Oncology

Pharmaceutical ManufacturingBasel-stadt, Switzerland10001+ Employees

At Novartis, our mission is to discover new ways to improve and extend people's lives. We use science-based innovation to address some of society's most challenging healthcare issues. We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible.

At Novartis, we focus on five key cancer areas where we have identified patient needs and promise within our portfolio - breast cancer, lung cancer, melanoma, kidney cancer and hematology. As a leader in oncology, Novartis offers a portfolio treating more than 25 conditions worldwide and approximately 30 compounds in development.

We are passionate about what we do and the impact we have on patients and societies. We are Novartis, and we are reimagining medicine.

See our community guidelines: https://go.novartis.social/4bqbjuA

Section iconCompany Overview

NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Employees
10001+

Section iconFunding & Financials

  • $2.4B

    Novartis Oncology has raised a total of $2.4B of funding over 3 rounds. Their latest funding round was raised on Sep 16, 2020 in the amount of $2.1B.

  • $1B$10B

    Novartis Oncology's revenue is estimated to be in the range of $1B$10B

Section iconFunding & Financials

  • $2.4B

    Novartis Oncology has raised a total of $2.4B of funding over 3 rounds. Their latest funding round was raised on Sep 16, 2020 in the amount of $2.1B.

  • $1B$10B

    Novartis Oncology's revenue is estimated to be in the range of $1B$10B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.